WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087947) A NOVEL POLYPEPTIDE-HUMAN CCR4 PROTEIN 10 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087947    International Application No.:    PCT/CN2001/000700
Publication Date: 22.11.2001 International Filing Date: 08.05.2001
IPC:
A61K 38/00 (2006.01), C07K 14/715 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 3rd Building 12th Floor 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00 1 15620.9 09.05.2000 CN
Title (EN) A NOVEL POLYPEPTIDE-HUMAN CCR4 PROTEIN 10 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
(FR) PROTEINE 10 DE CCR4 HUMAIN ET POLYNUCLEOTIDE LA CODANT
Abstract: front page image
(EN)The invention discloses a new kind of human CCR4 protein 10 and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also discloses the method of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, hemopathy, HIV infection, immune disease and inflammation. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said human CCR4 protein 10.
(FR)L'invention concerne un polypeptide humain, une protéine 10 de CCR4, le polynucléotide qui la code et un procédé de production de ce polypeptide à l'aide de technologie de recombinaison. Elle concerne aussi un méthode d'application de ce polypeptide pour le traitement de troubles variés, tels que tumeur maligne, hémopathie, infection VIH, maladie immunologique et inflammation. Elle concerne encore l'antagoniste du polypeptide et son utilisation thérapeutique. Elle concerne enfin l'utilisation du polynucléotide codant la protéine 10 de CCR4 humain.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)